Section 1: Introduction; 1 Giancarlo Logroscino and Rosanna Tortelli: Epidemiology of neurodegenerative diseases; 2 Luigi Barberini, Luca Saba, Claudia Fattuoni, Matteo Fraschini, and Francesco Marrosu: Metabolomics of neurodegenerative disorders; 3 James D Mills and Michael Janitz: Transcriptome profiling in neurodegenerative disorders; 4 Thomas Rapp, Pauline Chauvin, Nadege Costa, and Laurent Molinier: Health economic considerations in neurodegenerative disorders; 5 Robert Laforce, M. Lehmann, J. Macoir, S. Poulin, M. Roy, J.-P. Soucy, L. Verret, B. L. Miller, and R. W. Bouchard: Symptoms of neurodegenerative diseases; Section 2: Imaging Technique; 6 Michele Anzidei: Computed Tomography; 7 Aart J. Nederveen, Matthan W.A. Caan, and Marion Smits: General principles of Magnetic Resonance Imaging; 8 Juergen Dukart and Bogdan Draganski: Nuclear medicine and radiology; 9 Vivekanandan Palaninathan, Sivakumar Balasubramanian, D. Sakthi Kumar: Molecular imaging and neurodegenerative diseases; 10 Christopher Kobylecki, Alexander Gerhard, and Karl Herholz: PET imaging in neurodegenerative disorders - evolving techniques and new tracers; 11 Shankar Vallabhajosula, Brigitte Vallabhajosula, and Lilja Solnes: Radiopharmaceuticals for molecular imaging of neurodegenerative diseases; Section 3: Neurodegeneration: Cognition; 12 Charles D. Smith and Brian T. Gold: Neuroimaging of Alzheimer's disease; 13 F. Garaci, N. Toschi, T. Volpi, G. Gareffa, L. Spies, S.Lista, H. Hampel: MRI-based imaging of Alzheimer's disease; 14 Jennifer L. Whitwell: Frontotemporal dementia; 15 Claire Henchcliffe and Thomas Tropea: Dementia with Lewy Bodies; 16 Luke A Massey and Sean O'Sullivan: Corticobasal Syndrome and Corticobasal Degeneration; Section 4: Nueorregeneration: Movement; 17 Ana M. Franceschi, Sofia Pina, and Mauricio Castillo: Parkinson's disease: Clinical and Imaging Features; 18 Dominic Paviour: Progressive Supranuclear Palsy (PSP); 19 SJA van den Bogaard and RAC Roos: Imaging in Huntington's disease; 20 Keita Sakurai: Multiple system atrophy; Section 5: Neurodegeneration: Strength; 21 Martin R. Turner: Amyotrophic Lateral Sclerosis; Section 6: Neurodegeneration: Coordination; 22 Ana Solodkin, Gulin Oz, and Christopher M Gomez: Spinocerebellar Atrophies; 23 Hamed Akhlaghi, Martin B. Delatycki, Nellie Georgiou-Karistianis, and Gary F. Egan: Imaging in Neurodegenerative Disorder- Friedreich Ataxia; 24 Damien Galanaud: Neuroimaging in human prion diseases; Section 7: Neurodegeneration: PNS\ANS; 25 Erez Nossek & Tali Jonas Kimchi: Amyloidosis; 26 Amogh Hedge and CC Tchoyoson Lim: Metabolic and toxin related neurodegeneration; Section 8: Neurodegeneration: Myelin; 27 Eytan Raz: Demyelinating diseases; 28 Jose Berciano and Elena Gallardo: Charcot-Marie-Tooth disease; 29 Lev Bangiyev, Alexandra Roudenko, Eytan Raz, August Dietrich, Girish M. Fatterpekar: Neurodegenerative Disorders of the Basal Ganglia; Section 9: Neurodegeneration: Trauma; 30 Jan Booij, Francoise J Siepel, Tirza C Buter, and Dag Aarsland: Clinical benefit of dopamine transporter imaging in movement disorders and dementia; 31 Erin D. Bigler: Neurodegeneration post trauma: Brain; 32 J.A. Petersen, Spyros S. Kollias: Neurodegeneration post trauma: spine; 33 Duan Xiao-Hui and Jun Shen: Neurodegeneration post trauma: Peripheral nerves; Section 10: Neuroimaging after therapy; 34 A.L. Bartels, R. Hilker: Functional imaging of neurosurgery in Parkinson's disease; 35 Tsui A, Piccini P: Neuroimaging after Cell-Based Therapy

Diagnosing neurodegenerative diseases can prove particularly intimidating to clinicians, because many times the diagnosis cannot be critically "confirmed" by a simple test. New imaging modalities have advanced to the point of high resolution, morphological, metabolic and functional analysis. Computed tomography, magnetic resonance, nuclear medicine and molecular imaging have recently emerged as outstanding non-invasive techniques for the study of the neurodegenerative disorders.
Imaging in Neurodegenerative Disorders covers all the imaging techniques and new exciting methods like new tracers, biomarker, metabolomic and gene-array profiling, potential for applying such techniques clinically, and offers present and future applications as applied to the neurodegenerative disorders with the most world renowned scientists in these fields. This book is an invaluable resource for researchers, clinicians, and trainees in neuroscience, neurology, psychiatry, and radiology.

Luca Saba received the MD from the University of Cagliari, Italy in 2002. Today he works in the Azienda Ospedaliero Universitaria of Cagliari. Dr Saba research fields are focused on Multi-Detector-Row Computed Tomography, Magnetic Resonance, Ultrasound, Neuroradiology, and Diagnostic in Vascular Sciences.
Dr. Saba has won 15 scientific and extracurricular awards during his career. He has presented more than 450 papers and posters in National and International Congress (RSNA, ESGAR, ECR, ISR, AOCR, AINR, JRS, SIRM, AINR). He wrote 18 book-chapters and he is Editor of 7 books in the field of Computed Tomography, Cardiovascular, Plastic Surgery, Gynecological Imaging and Neurodegenerative imaging.
He is member of the Italian Society of Radiology (SIRM), European Society of Radiology (ESR), Radiological Society of North America (RSNA), American Roentgen Ray Society (ARRS) and European Society of Neuroradiology (ESNR) and serves as Reviewer of more than 30 scientific journals.